在患有复发性宫癌的两名患者中,原发性和转移性瘤之间的PD-L1表达的差异

Brittany File1, Anjali Hari2

  • 1Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange, CA, USA.

Gynecologic oncology reports
|September 10, 2024
PubMed
概括

布罗利祖马布已获批准用于基于PD-L1表达的复发性宫癌. 这份报告强调了原发性和转移性瘤之间PD-L1表达的差异,影响了治疗决策和患者的治疗结果.

相关概念视频